Abvc Biopharma (ABVC) Research & Development (2015 - 2026)
Abvc Biopharma's Research & Development came in at $18,040 for Q3 2026, down 39.6% from $29,890 a year earlier and down 20.6% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Research & Development (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Abvc Biopharma reported Research & Development of $102,905, down 17.0% year-over-year; for FY2025, it came in at $121,085, down 32.5% from FY2024.
- Research & Development has declined in each of the last three years, with a five-year compound annual growth rate of -26.1% (FY2020 to FY2025).
- Going back by year, Research & Development was $179,272 in FY2024 (-83.1%), $1.06 million in FY2023 (-60.5%), $2.69 million in FY2022 (+168.3%) and $1 million in FY2021 (+82.6%).
- The Q3 2026 figure represents the lowest quarterly Research & Development since Q3 2017.
- Year-over-year, Research & Development increased in 1 of the last eight quarters, with an average decline of 27.3%.
- The fastest year-over-year change in Research & Development over five years came in Q4 2022 (growth of 474.9%), and the weakest in Q4 2023 (a decline of 95.2%).
- Business Quant data shows ABVC's Research & Development at $22,707 (Q2 2026), $33,100 (Q1 2026) and $29,058 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | 18,040.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 18,040.00 |
| Jun 30, 2026 | 22,707.00 |
| Mar 31, 2026 | 33,100.00 |
| Dec 31, 2025 | 29,058.00 |
| Sep 30, 2025 | 29,890.00 |
| Jun 30, 2025 | 33,276.00 |
| Mar 31, 2025 | 28,861.00 |
| Dec 31, 2024 | 31,980.00 |
| Sep 30, 2024 | 37,825.00 |
| Jun 30, 2024 | 40,401.00 |
| Mar 31, 2024 | 69,066.00 |
| Dec 31, 2023 | 72,185.00 |
| Sep 30, 2023 | 141,310.00 |
| Jun 30, 2023 | 514,442.00 |
| Mar 31, 2023 | 334,979.00 |
| Dec 31, 2022 | 1.50 Mn |
| Sep 30, 2022 | 305,483.00 |
| Jun 30, 2022 | 532,782.00 |
| Mar 31, 2022 | 359,404.00 |
| Dec 31, 2021 | 260,188.00 |
API Access
Abvc Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();